ASDAS-CRP and ASDAS-ESR cut-offs for disease activity states in axial spondyloarthritis - Are they interchangeable?
CONCLUSION: We estimated the optimal ASDAS-ESR values corresponding to the established ASDAS-CRP cut-off values. However, applying the estimated cut-offs did not increase the level of agreement between ASDAS-ESR and ASDAS-CRP disease activity states to a relevant degree. Our findings did not provide evidence to reject the established cut-off values for ASDAS-ESR.PMID:38621792 | DOI:10.3899/jrheum.2023-1217 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - April 15, 2024 Category: Rheumatology Authors: Stylianos Georgiadis Lykke Midtb øll Ørnbjerg Brigitte Michelsen Tore K Kvien Daniela Di Giuseppe Johan K Wallman Jakub Z ávada Sella A Provan Eirik Klami Kristianslund Ana Maria Rodrigues Maria Jos é Santos Žiga Rotar Katja Perdan Pirkmajer Dan Nord Source Type: research
Feasibility of physiotherapist-led rheumatology triage: A randomized study
CONCLUSION: Physiotherapist-led triage was feasible, appeared as reliable as rheumatologist triage of referrals for joint pain, and lead to significantly fewer patients requiring in-clinic visits.PMID:38621798 | DOI:10.3899/jrheum.2023-1071 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - April 15, 2024 Category: Rheumatology Authors: Janet H Roberts Cheri Gun Jennifer E Mackinnon Susan Parlee Volodko Bakowsky Trudy Taylor Claire E H Barber John G Hanly Source Type: research
When Should I Get My Next COVID Vaccine? Data from the SUrveillance of responses to COVID-19 vaCcines in systEmic immunE mediated inflammatory Diseases (SUCCEED)study
CONCLUSION: Ours is the first pan-Canadian IMID assessment of how vaccine history and other factors affect serologic COVID-19 vaccine responses. These findings may help individuals personalize vaccination decisions, including consideration of additional vaccination when >6 months has elapsed since last COVID vaccination/infection.PMID:38621797 | DOI:10.3899/jrheum.2023-1214 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - April 15, 2024 Category: Rheumatology Authors: Dawn M E Bowdish Vinod Chandran Carol A Hitchon Gilaad G Kaplan J Antonio Avina-Zubieta Paul R Fortin Maggie J Larch é Gilles Boire Anne-Claude Gingras Roya M Dayam Ines Colmegna Luck Lukusa Jennifer L F Lee Dawn P Richards Daniel Pereira Tania H Watts M Source Type: research
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)
CONCLUSION: The 5-year benefit-risk profile for upadacitinib in RA remains favorable.PMID:38621793 | DOI:10.3899/jrheum.2023-1062 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - April 15, 2024 Category: Rheumatology Authors: Gerd R Burmester Filip Van den Bosch John Tesser Anna Shmagel Yanxi Liu Nasser Khan Heidi S Camp Alan Kivitz Source Type: research
Investigation of the mechanism of nephrotoxicity of nux-vomica by PTGS2/CYP2C9-mediated arachidonic acid pathway and Jian Pi Tong Luo compound's protective effect
This study establishes a scientific foundation for the clinical use of nux-vomica and lays groundwork for further research and safety assessment of toxic Chinese herbal medicines.PMID:38618996 | DOI:10.1002/bmc.5859 (Source: Biomedical Chromatography : BMC)
Source: Biomedical Chromatography : BMC - April 15, 2024 Category: Biomedical Science Authors: Na Zhang Baisong An Liangyou Zhao Dapeng Zhao Bochuan Lv Shumin Liu Source Type: research
Impact of a resilience-building energy management intervention for people with systemic sclerosis: a mixed methods study
CONCLUSION: Incorporating peer health coaches and technology is beneficial for self-management interventions for people with SSc. Future tailoring of RENEW based on SSc duration and symptom severity is needed.CLINICAL TRIAL REGISTRATION NUMBER: clinicatrials.gov, NCT04908943.PMID:38618141 | PMC:PMC11015950 | DOI:10.1093/rap/rkae040 (Source: Adv Data)
Source: Adv Data - April 15, 2024 Category: Epidemiology Authors: Yen T Chen Alexandra E Harper Tiffany Phanhdone Mary Alore Sheri Hicks Adam Pape Gina M Jay Shannen Bolde Jennie Feldpausch Timothy C Guetterman Dinesh Khanna Susan L Murphy Source Type: research
Drug survival and change of disease activity using a second janus kinase inhibitor in patients with difficult-to-treat rheumatoid arthritis who failed to a janus kinase inhibitor and subsequent biologics
CONCLUSIONS: Second JAKi could be a therapeutic option in patients with difficult-to-treat RA who have failed to a JAKi and subsequent bDMARDs.PMID:38622706 | DOI:10.1186/s42358-024-00368-w (Source: Adv Data)
Source: Adv Data - April 15, 2024 Category: Epidemiology Authors: Oh Chan Kwon Wonho Choi Soo Min Ahn Ji Seon Oh Seokchan Hong Chang-Keun Lee Bin Yoo Min-Chan Park Yong-Gil Kim Source Type: research
Rheumatology: What You May Have Missed in 2023
Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0678. Online ahead of print.ABSTRACTMany patients with rheumatologic conditions receive care from physicians other than rheumatologists. Here we note key findings from 6 studies in rheumatology published in 2023 that offer valuable insights for internal medicine specialists and subspecialists outside of rheumatology. The first study investigated the effect of low-dose glucocorticoids on patients with rheumatoid arthritis (RA) over 2 years and challenged existing perceptions about the risks of glucocorticoids in this setting. The second study focused on the updated guideline for...
Source: Annals of Internal Medicine - April 15, 2024 Category: Internal Medicine Authors: Kafaf Jalali Lisa A Mandl Source Type: research
The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis
Ann Intern Med. 2024 Apr;177(4):545. doi: 10.7326/L24-0003.NO ABSTRACTPMID:38621264 | DOI:10.7326/L24-0003 (Source: Annals of Internal Medicine)
Source: Annals of Internal Medicine - April 15, 2024 Category: Internal Medicine Authors: Daniel Arkfeld Sofia Audrey B Gonzales Katherine Ruddy Source Type: research
The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis
Ann Intern Med. 2024 Apr;177(4):545-546. doi: 10.7326/L24-0004.NO ABSTRACTPMID:38621265 | DOI:10.7326/L24-0004 (Source: Annals of Internal Medicine)
Source: Annals of Internal Medicine - April 15, 2024 Category: Internal Medicine Authors: Kavita Narula Katharine Lazarus Sirazum Choudhury Karim Meeran Source Type: research
The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis
Ann Intern Med. 2024 Apr;177(4):546. doi: 10.7326/L24-0005.NO ABSTRACTPMID:38621266 | DOI:10.7326/L24-0005 (Source: Annals of Internal Medicine)
Source: Annals of Internal Medicine - April 15, 2024 Category: Internal Medicine Authors: Alexander Theophilopoulos Michael R Bubb Source Type: research
The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis
Ann Intern Med. 2024 Apr;177(4):546-547. doi: 10.7326/L24-0006.NO ABSTRACTPMID:38621267 | DOI:10.7326/L24-0006 (Source: Annals of Internal Medicine)
Source: Annals of Internal Medicine - April 15, 2024 Category: Internal Medicine Authors: Andriko Palmowski Maarten Boers John Kirwan Robin Christensen Frank Buttgereit Source Type: research
Predictors of damage accrual and its impact on health-related quality of life of thrombotic antiphospholipid syndrome: Independent validation of the damage index for antiphospholipid syndrome (DIAPS)
CONCLUSION: This external validation of DIAPS reinforces the ability of the score to correlate with HR-QoL while also highlighting risk factors for HR-QoL impairment other than damage accrual.PMID:38616341 | DOI:10.1177/09612033241246360 (Source: Lupus)
Source: Lupus - April 15, 2024 Category: Rheumatology Authors: Pedro Gaspar Ana Sofia M Fernandes Ana Mafalda Abrantes In ês Parreira In ês Silva Ryan C Silva Mariana B Nobre Joana R Martins Catarina Mota Source Type: research
Extracellular mitochondrial components as new biomarkers for lupus nephritis
This study has evaluated extracellular mitochondrial components, including cell-free mitochondria, and cell-free mitochondrial DNA as probable biomarkers of the degree of nephritis. Both showed a significant correlation with proteinuria and protein-creatinine ratio. Our study substantiates their usage as clinical biomarkers of nephritis upon their validation in a larger cohort of lupus nephritis patients and other forms of nephritis. Although the current data suggest using cell-free mitochondria as a biomarker of lupus nephritis is better than the cell-free mitochondrial DNA.PMID:38621786 | DOI:10.1177/09612033241247622 (Source: Lupus)
Source: Lupus - April 15, 2024 Category: Rheumatology Authors: Sharath Gowda Khushboo Rana Ankit Kumar Pradip Kumar Prajapati Namisha Patel Sapan Pandya Ratika Srivastava Source Type: research
Response to kollas. Letter to the editor, "problems with opioids beyond misuse"
Best Pract Res Clin Rheumatol. 2024 Apr 13:101946. doi: 10.1016/j.berh.2024.101946. Online ahead of print.NO ABSTRACTPMID:38616455 | DOI:10.1016/j.berh.2024.101946 (Source: Clin Med Res)
Source: Clin Med Res - April 15, 2024 Category: Research Authors: Deeba Minhas Dorna Kheirabadi Rezvan Ghaderpanah Daniel J Clauw Source Type: research
